nih-small-business-programs-logo

Stephanie Fertig and Kory Hallett from the National Institutes of Health (NIH) will give an overview of SBIR and STTR Small Business programs at the NIH.

The talk will include:

  • A description of the programs and goals
  • Tips on applying
  • Resources available to researchers and small/startup businesses interested in translating their technologies into commercial products.

At the end of their presentation, the speakers will respond to questions from the audience.

If you want to find ways to expand your biomedical startup using NIH funding, you won't want to miss this webinar!

apptio-logo

T. Rowe Price sunk gobs of money into companies such as Cloudera, Dropbox, Apptio and Evernote in recent years, oftentimes at lofty valuations.

Now, the giant mutual fund manager is resetting some of those bets. According to a report in The Information (subscription required), T. Rowe Price has marked down its stakes in a number of companies.

GlaxoSmithKline-gsk-logo

British pharmaceutical firm GlaxoSmithKline is reportedly discussing terms of a medtech joint venture with US chipmaker Qualcomm.

Talks between the two companies to form a partnership to develop medical technology are "preliminary and nothing has been decided", reports Bloomberg, citing unnamed sources privy to the information. The Financial Times says the deal could be worth as much as $1 billion, and GSK reportedly has hired lawyers to help negotiate the terms of the joint venture with Qualcomm. If confirmed, FT expects the companies "to pool financial and human resources in a joint effort to develop new technology for use in the pharmaceuticals industry."

datapalooza-2016-logo

May 8 - 11, 2016 - Grand Hyatt Washington DC in Washington, DC

Health Datapalooza is a national conference focused on liberating health data, and bringing together the companies, startups, academics, government agencies, and individuals with the newest and most innovative and effective uses of health data to improve patient outcomes.

roche-logo

Roche will partner with the Lead Discovery Center (LDC) to identify and advance drug discovery projects intended to address diseases of unmet medical need across several areas. The value of the collaboration and the diseases to be addressed were not disclosed by the LDC, which announced the partnership today.

women-in-bio-logo

WIB has collaborated with BioProcess International (BPI), the biopharmaceutical industry´s leading scientific publication, to publish a four-part WIB/BPI special report series in 2016. The mission of this special report series is to provide a unique and interactive platform to reach and educate women (and all professionals) working in the life sciences with insight, mentorship, and leadership support through all stages of career development. Each edition of the WIB/BPI special report series will focus on critical issues all biotechnology professionals need to know, understand and manage in order to climb the corporate ladder and achieve the highest levels of leadership.

2016-nist-industry-day-logo

This is an opportunity to hear from NIST's leadership about their important mission, a multi-million dollar laboratory expansion, cybersecurity implementation, and vendor opportunities in construction and IT.

Participants will also have the opportunity to meet representatives from many of the NIST Operating Units and contracting officials at exhibitor tables, speak one-on-one with the panelists, and network with fellow government contractors.

the-next-silicon-valley-logo

More innovation will be the determining factor in achieving greater progress. Countries’ economic and trade policies can either help or hurt global innovation. For example, policies such as robust investment in and tax incentives for research and education support global innovation. In contrast, policies such as export subsidies or forced localization harm global innovation.

umd-maryland-logo

The White House has awarded Robert E. Fischell, ScD, a member of the University of Maryland School of Medicine (UM SOM) Board of Visitors, the National Medal of Technology and Innovation, the highest honor for technological achievement bestowed by the president of the United States. Previous recipients have included such luminaries as Steven Jobs and Stephen Wozniak (Apple Computer, Inc.), Stephen D. Bechtel, Jr. (Bechtel Group, Inc.), David Packard (Hewlett-Packard Company), Clarence L. Johnson (Lockheed Corporation), Edwin H. Land (Polaroid Corporation) and Edith Flanigen (Union Carbide).

montgomery-economica-development-logo

DATE: Wednesday, February 10, 2016

LOCATION: Montgomery County Department of Economic Development, 111 Rockville Pike, Suite 800, Rockville, MD 20850

Southern Maryland's Energetics Technology Center (ETC-MD) announces it is opening Montgomery County's newest technology business incubator as part of the ETC-MD TechFire incubator network at the former National Labor College located at 10000 New Hampshire Avenue.  This incubator is sponsored by the Army Research Labs and is purposed to serve companies interested in commercializing ARL developed technologies although other technology companies will be considered as well.  Find out how you can work successfully with the Army Research Lab at this informative session.  

pfizer-logo

Pfizer Inc. (NYSE:PFE) today announced an expansion of its Research & Development (R&D) investment strategy to include early-stage companies on the leading edge of scientific innovation, providing them with both equity and access to resources for research in promising areas aligned with Pfizer’s core interests. The first four investments of the newly focused initiative include $46 million in financing to companies at early stages of the discovery process that are actively exploring Conditionally Active Biologics (CABs), immuno-oncology, neurodegenerative technologies and gene therapy. Additional opportunities will continue to be identified by Pfizer’s scientific leadership through their active involvement, and Pfizer will help recipient companies fully explore their platforms in the hopes of advancing new therapeutic pathways.

biotechnology-industry-organization-logo

To better reflect the remarkable progress and groundbreaking innovations its members achieve in healing, fueling and feeding the world, BIO – the world's largest biotechnology trade association – is changing its name to Biotechnology Innovation Organization. The organization will continue to use the shortened, “BIO” name.

In the more than 22 years since its founding, BIO – formerly Biotechnology Industry Organization – has united scientists, entrepreneurs, policymakers and the public to advance breakthrough cures and products in fields ranging from health, food and agricultural to industrial and environmental.

emergent-biosolution-logo

Emergent BioSolutions Inc. (NYSE:EBS) today announced the anticipated executive management team of Aptevo Therapeutics Inc., Emergent’s planned Biosciences business spin-off company. Members of the Aptevo executive management team will be appointed to their positions effective upon completion of the tax-free spin-off of Aptevo, expected to occur in mid-2016.

“We are pleased to have such an experienced and talented group of individuals to lead Aptevo Therapeutics,” said Daniel J. Abdun-Nabi, president and chief executive officer of Emergent BioSolutions. “These individuals possess the expertise, commitment, and passion to build on the successes of Emergent’s biosciences business for it to grow as a stand-alone publicly-traded company.”

umd-maryland-logo

As a result of research performed by scientists at the University of Maryland School of Medicine (UM SOM), the U.S. Food and Drug Administration (FDA) has approved the use of a drug to treat the deleterious effects of radiation exposure following a nuclear incident. The drug, Neulasta®, is one of a very small number that have been approved for the treatment of acute radiation injury.

The research was done by Thomas J. MacVittie, PhD, professor, and Kim Hankey, PhD, Study Director, both in the Preclinical Radiobiology Laboratory at the University of Maryland School of Medicine Department of Radiation Oncology's Division of Translational Radiation Sciences (DTRS). The investigators did their research in a non-human clinical model of high-dose radiation. Ann M. Farese, MA, MS, assistant professor in the same lab and department, also contributed to the work.

usda-webinar-2016-image

February 16, 2016 2:30pm EST

Are you a scientist, entrepreneur, business developer, investor or economic development professional working in the area of human nutrition, animals, plants or sustainable agriculture? Are you interested in collaborating with world class scientists to scale up promising technologies? If these questions resonate with you, then this is a webinar for you!

ARS utilization centers are available for establishing partnerships to scale-up ARS research into commercial processes. Each of these state-of-the-art utilization centers has a unique set of resources, facilities, technical experts and scientific research capabilities for the industrial scaleup of lab-based technologies

Shares for care mann rotator

SHARE For Cures (SFC), a new Washington, DC-based non-profit that makes it easy for individuals to access and securely share their health data with researchers, announced today a new partnership with BioHealth Innovation, a Maryland-based innovation intermediary focused on connecting health technology innovators and entrepreneurs with government agencies and corporations.

Through the partnership, SHARE For Cures will become an affiliate of Relevant Health, a Rockville, MD-based technology accelerator supported by BioHealth Innovation.

johns-hopkins-logo

It's wise to think ahead when it comes to cancer, says William Nelson, one of the nation's leading oncologists and director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University.

That includes taking steps like avoiding tobacco and tanning beds, especially when you're young.

moon-sky-pixa

In his final State of the Union address, President Obama announced a "moonshot" program to cure cancer. Obama named Vice President Joe Biden, whose son Beau died from brain cancer last year, to lead the government effort, which could even have bipartisan appeal. In 2015, House Republicans and Democrats overwhelmingly passed the 21st Century Cures Act, which raises funding and lowers barriers for audacious medical research. (The Senate is considering its own version.) The bill's sponsor (and Chairman of the House Energy and Commerce Committee), Fred Upton, tweeted his support for the Obama-Biden effort.

washington-dc-night-pixa

The Washington region could hit the billion-dollar mark in cybersecurity venture funding in 2016. Jonathan Aberman, managing director of Amplifier Ventures, a seed and early-stage venture capital fund based in McLean, said big fourth-quarter investments in cybersecurity companies helped boost overall venture funding in 2015 – and will continue to grow in 2016. He said the Washington region, a growing center for cybersecurity business and research overall, will see more big deals in 2016.

columbia-engineering-logo

Last year, three biomedical engineering (BME) MS students—Teresa Cauvel, Rebecca Peyser, and Sona Shah—took BME Lecturer Katherine E. Reuther’s new design course and came up with an idea for a health technology startup they called Neopenda. Their concept, born in January and shaped through Reuther’s class over the spring semester, was a low-cost, low-power, low-maintenance way to monitor neonatal vitals through engineered “hats,” a headband containing a small circuit that measures heart rate, respiratory rate, temperature, and blood oxygen saturation in critically ill infants and then sends the data to a centralized monitoring device.

jp-morgan-healthcare-conference-logo

Our livers rested, our business cards sheathed – one more year of the J.P. Morgan Healthcare Conference has come and gone. Given that the week was relatively quiet in terms of breaking news, the focus rested more solidly on trend analysis, moodiness – and what was not said. It also showed undercurrents of change.

german-accelerator-logo

Germany has a long-standing reputation for life science innovation. However, most pharmaceutical and biotech companies are now headquartered in the US, and significantly more digital health solutions are developed in Silicon Valley and Boston than in Berlin or Munich.

aging-20-logo

At its recent AgeTech Expo, Aging2.0 held the 3rd annual Pitch-for-Pilots (P4P) competition where market-ready startups pitched their innovations to senior care providers in the audience in hopes of securing pilot partnerships.    Selected from more than 150 applications, the pitching companies presented the challenge they are addressing, their solution, what kind of pilot they would like to run and any requirements for the potential provider partner. The prize at hand for senior care partners? A free, 6-week pilot with at least 10 senior participants. 

TEDxBaltimore-logo

Hundreds of people packed into Morgan State University’s Murphy Fine Arts Center on Thursday for this year’s TEDxBaltimore. FEATURED JOBS Design Assistant / Project Manager C.N.Robinson

Entry Level Management Trainee - Marketing / Sales / PR GVG, Inc. Med Tech/CNA/Caregiver Brightview Senior Living Post a JobSee More Jobs The day-long event featured 15-minute talks from 17 speakers on topics ranging from scientific discovery and space exploration to prison reform and racial inequality. There were too many interesting ideas to talk about them all, but here are a few that captured my attention:

eagb-regional-report-2015-cover

"We have released our annual Regional Report. The report benchmarks the region against other metropolitan regions, the national average and specifically markets comparable to the Greater Baltimore region. This year’s report analyzes the region’s employment, innovation, quality of life, jobs and investment."

us-doe-logo

This position is located in the Office of Technology Transitions and reports directly to the Director, Office of Technology Transitions. If selected for this position, you will manage the OTT staff, as the advisor to the Director, and provide continuity between administrations. The Deputy Director will be a senior level staff serving as a point of contact for entities like the Laboratory Operations (LOB), Laboratory Policy Council (LPC), and Secretary's External Advisory Board (SEAB). The Deputy Director will manage the intra-agency tech Transfer Policy Board (TTPB). The Deputy Director will serves as an integral part of the Office of Technology Transitions, overseeing the day-today operations of the Office, continuously seeking efficiencies by providing oversight and coordination. The Deputy Director will develop and manage fit-for purpose oversight processed and procedures for technology transfer and reporting systems, including intellectual property, across the DOE enterprise. The Deputy Director will lead the development of annual OTT deliverables, working with appropriate DOE programmatic elements. The Deputy Director will lead OTT staff to ensure delivery of state of the art data management processes and solutions supporting effective technology transitions and outreach to the private sector. The Deputy Director will lead interactions needed with the Executive Office of the White House, the Office of Management and Budget (OMB), the General Services Administration (GSA), Congressional Committees and Subcommittees, State Officials, the non-profit sector, and other non-commercial entities to ensure DOE technology transitions polices and priorities are appropriately linked with related initiatives, and to improve existing, or develop new, processes and procedures for supporting technology transfer solutions.

biotechnology-industry-organization-logo

The Obama administration has launched a ‘moonshot’ initiative to cure cancer that will involve increasing resources – both private and public – to fight cancer and break down walls between disciplines in the oncology arena. The effort will be led by vice president Joe Biden, who lost his son to brain cancer last year, President Obama announced during his final State of the Union speech. Biden worked with Congress last month to provide the US National Institutes of Health with its strongest budget in over a decade, Obama noted. ‘Let’s make America the country that cures cancer once and for all,’ he added.